Drawing for ANARA HEALTH

USPTO serial 97776061

ANARA HEALTH

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MOLINOFF, JEFFREY S.
Law office
PETITIONS OFFICE

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with ANARA HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ernest G. Bootsma

Ernest G. Bootsma BUCHALTER, APC805 S.W. BROADWAY, SUITE 1500PORTLAND, OR 97205United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for use by patient sponsors, guardians, representatives, and support persons to identify patients who are located in or will be treated in India, engage doctors, treatment facilities, and health care workers to treat patients who are located in or will be treated in India, to schedule medical treatments and procedures for patients who are located in or will be treated in India, and to pay for health care services for patients who are located in or will be treated in IndiaACTIVE—
042Software as a service (SAAS) services featuring software for use by patient sponsors, guardians, representatives, and support persons to identify patients who are located in or will be treated in India, engage doctors, treatment facilities, and health care workers to treat patients who are located in or will be treated in India, to schedule medical treatments and procedures for patients who are located in or will be treated in India, and to pay for health care services for patients who are located in or will be treated in IndiaACTIVE—
044Internet-based health care information services; Providing health care information via a global computer networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 5, 2026EX5GSOU EXTENSION 5 GRANTED—
Jul 31, 2026EXT5SOU EXTENSION 5 FILED—
Jul 31, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2026EX4GSOU EXTENSION 4 GRANTED—
Feb 6, 2026EXT4SOU EXTENSION 4 FILED—
Feb 6, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 6, 2025EX3GSOU EXTENSION 3 GRANTED—
Aug 6, 2025EXT3SOU EXTENSION 3 FILED—
Aug 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2025EX2GSOU EXTENSION 2 GRANTED—
May 29, 2025EX1GSOU EXTENSION 1 GRANTED—
May 29, 2025PGEXPETITION GRANTED - EXTENSION REQUEST FILED—
May 5, 2025ERTPTEAS RESPONSE TO PETITION DEFICIENCY RECEIVED—
Apr 4, 2025PINMINCOMPLETE PETITION NOTICE MAILED—
Apr 4, 2025APETASSIGNED TO PETITION STAFF—
Mar 24, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 6, 2025EXT2SOU EXTENSION 2 FILED—
Jan 14, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Jan 14, 2025PGEXPETITION GRANTED - EXTENSION REQUEST FILED—
Nov 12, 2024APETASSIGNED TO PETITION STAFF—
Oct 9, 2024PETRPETITION TO REVIVE-RECEIVED—
Oct 9, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Sep 9, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 9, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 6, 2024EXT1SOU EXTENSION 1 FILED—
Feb 6, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 12, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Nov 6, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 6, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 6, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 31, 2023DOCKASSIGNED TO EXAMINER—
Feb 19, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 17, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 7, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance